These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 17223627

  • 1. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.
    Ali V, Nozaki T.
    Clin Microbiol Rev; 2007 Jan; 20(1):164-87. PubMed ID: 17223627
    [Abstract] [Full Text] [Related]

  • 2. Sulfur-containing amino acid metabolism in parasitic protozoa.
    Nozaki T, Ali V, Tokoro M.
    Adv Parasitol; 2005 Jan; 60():1-99. PubMed ID: 16230102
    [Abstract] [Full Text] [Related]

  • 3. Parasite sulphur amino acid metabolism.
    Walker J, Barrett J.
    Int J Parasitol; 1997 Aug; 27(8):883-97. PubMed ID: 9292304
    [Abstract] [Full Text] [Related]

  • 4. Chemotherapeutic approaches to protozoa: Giardia, Trichomonas and Entamoeba--current level of knowledge and outlook.
    Harder A, Greif G, Haberkorn A.
    Parasitol Res; 2001 Sep; 87(9):785-6. PubMed ID: 11570567
    [Abstract] [Full Text] [Related]

  • 5. In Silico Analysis of Potential Drug Targets for Protozoan Infections.
    Juárez-Saldivar A, Campillo NE, Ortiz-Perez E, Paz-Gonzalez AD, Saavedra E, Rivera G.
    Med Chem; 2022 Sep; 19(1):91-98. PubMed ID: 35975866
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Targeting polyamines of parasitic protozoa in chemotherapy.
    Müller S, Coombs GH, Walter RD.
    Trends Parasitol; 2001 May; 17(5):242-9. PubMed ID: 11323309
    [Abstract] [Full Text] [Related]

  • 10. Kinetic characterization of methionine gamma-lyases from the enteric protozoan parasite Entamoeba histolytica against physiological substrates and trifluoromethionine, a promising lead compound against amoebiasis.
    Sato D, Yamagata W, Harada S, Nozaki T.
    FEBS J; 2008 Feb; 275(3):548-60. PubMed ID: 18199285
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Drugs for protozoan diseases].
    Ohta N.
    Nihon Rinsho; 2007 Feb 28; 65 Suppl 2 Pt. 1():380-3. PubMed ID: 17455649
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anaerobic energy metabolism in human microaerophile parasites.
    Carvalho-de-Araújo AD, Carvalho-Kelly LF, Meyer-Fernandes JR.
    Exp Parasitol; 2023 Apr 28; 247():108492. PubMed ID: 36841468
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transcriptional and functional analysis of trifluoromethionine resistance in Entamoeba histolytica.
    Penuliar GM, Furukawa A, Nakada-Tsukui K, Husain A, Sato D, Nozaki T.
    J Antimicrob Chemother; 2012 Feb 28; 67(2):375-86. PubMed ID: 22110087
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular biology of the amitochondriate parasites, Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.
    Vanacova S, Liston DR, Tachezy J, Johnson PJ.
    Int J Parasitol; 2003 Mar 28; 33(3):235-55. PubMed ID: 12670510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.